ENTITY
SK Bioscience

SK Bioscience (302440 KS)

232
Analysis
Health Care • South Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
Exchange Announcement • 12 Aug 2026 15:54

Organization of Investor Relations Event

Exchange Announcement • 12 Aug 2026 15:47

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Exchange Announcement • 10 Aug 2026 16:02

Organization of Investor Relations Event

Exchange Announcement • 10 Aug 2026 15:52

Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Exchange Announcement • 29 Jul 2026 16:13

Organization of Investor Relations Event

x